HIGH-DOSE PULSE CHLORAMBUCIL - EFFECTIVE THERAPY FOR RAPID REMISSION INDUCTION IN NODULAR LYMPHOCYTIC POORLY DIFFERENTIATED LYMPHOMA

被引：0
|
作者：
CADMAN, E
DRISLANE, F
WALDRON, JA
FARBER, L
PROSNITZ, L
BERTINO, JR
机构：
[1] YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510
[2] YALE UNIV,SCH MED,DEPT PATHOL,NEW HAVEN,CT 06510
[3] YALE UNIV,SCH MED,DEPT THERAPEUT RADIOL,NEW HAVEN,CT 06510
来源：
CANCER | 1982年 / 50卷 / 06期
关键词：
D O I：
10.1002/1097-0142(19820915)50:6<1037::AID-CNCR2820500603>3.0.CO;2-N
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1037 / 1041
页数：5
相关论文
共 50 条
  • [31] High-dose cytarabine and idarubicin (HDAC/IDA) is effective remission induction therapy for older de novo but not for secondary acute myeloid leukemia (AML) patients.
    Baer, MR
    Pixley, LA
    Lawrence, D
    O'Loughlin, KL
    Abdel-Razeq, S
    Block, AW
    Sait, SNJ
    Wetzler, M
    Christiansen, NP
    Frankel, SR
    Herzig, GP
    Bloomfield, CD
    BLOOD, 1998, 92 (10) : 231A - 231A
  • [32] HIGH-DOSE THERAPY AND ABMT IN PARTIAL REMISSION AFTER 1ST-LINE INDUCTION THERAPY FOR DIFFUSE NON-HODGKIN
    LASSET, C
    HARTMANN, O
    PHILIP, T
    BIRON, P
    CAHN, JY
    PEIN, F
    BORDIGONI, P
    GARIN, B
    SOUILLET, G
    GARTNER, M
    CHAUVIN, F
    BONE MARROW TRANSPLANTATION, 1988, 3 : 83 - 83
  • [33] A PHASE-II TRIAL OF INTERMITTENT LEUKOCYTE INTERFERON AND HIGH-DOSE CHLORAMBUCIL IN THE TREATMENT OF NON-HODGKINS LYMPHOMA RESISTANT TO CONVENTIONAL THERAPY
    CLARK, RH
    DIMITROV, NV
    AXELSON, JA
    CHARAMELLA, LJ
    STOTT, PB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (01): : 75 - 77
  • [34] Remission of the renal involvement in a patient with primary Sjogren's syndrome (SS) after pulse high-dose corticosteroid infusion therapy
    Saeki, Y
    Ohshima, S
    Ishida, T
    Shima, Y
    Umeshita-Sasai, M
    Nishioka, K
    Yamaguchi, N
    Suemura, M
    CLINICAL RHEUMATOLOGY, 2001, 20 (03) : 225 - 228
  • [35] High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience
    Cao, TM
    Horning, SF
    Negrin, RS
    Hu, WW
    Johnston, LF
    Taylor, TL
    Shizuru, JA
    Hoppe, RT
    Brown, BW
    Blume, KG
    Stockerl-Goldstein, K
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (05) : 294 - 301
  • [36] High-dose therapy and autologous transplantation in poor prognosis patients with diffuse large B-cell lymphoma in first remission
    Papajik, T.
    Raida, L.
    Faber, E.
    Prochazka, V.
    Vondrakova, J.
    Skoumalova, I.
    Kubova, Z.
    Jarosova, M.
    Jarkovsky, J.
    Dusek, L.
    Indrak, K.
    BLOOD REVIEWS, 2007, 21 : S93 - S93
  • [37] Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma
    Pott, C
    Schrader, C
    Gesk, S
    Harder, L
    Tiemann, M
    Raff, T
    Brüggemann, M
    Ritgen, M
    Gahn, B
    Unlerhalt, M
    Dreyling, M
    Hiddemann, W
    Siebert, R
    Dreger, P
    Kneba, M
    BLOOD, 2006, 107 (06) : 2271 - 2278
  • [38] High-dose therapy and autologous peripheral blood stem cell transplantation is an effective therapy in patients with acute myelogenous leukemia in first remission.
    Assawametha, TIN
    O'Charoen, R
    Sutcharitchan, P
    Swasdikul, D
    BLOOD, 1998, 92 (10) : 366B - 366B
  • [39] Efficacy and safety of high-dose of mycophenolate mofetil compared with cyclophosphamide pulse therapy as induction therapy in Japanese patients with proliferative lupus nephritis
    Ohkubo, Naoaki
    Iwata, Shigeru
    Nakano, Kazuhisa
    Miyagawa, Ippei
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Miyazaki, Yusuke
    Kawabe, Akio
    Nakayamada, Shingo
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2022, 32 (06) : 1077 - 1085
  • [40] Rituximab/chemotherapy induction treatment followed by high-dose therapy and autologous transplantation in patients with mantle cell lymphoma.
    Thieblemont, C
    Antal, D
    Lacotte-Thierry, L
    Delwail, V
    Bouafia, F
    Tartas, S
    Michallet, AS
    Espinouse, D
    Giraud, C
    Salles, G
    Guilhot, F
    Coiffier, B
    BLOOD, 2004, 104 (11) : 390A - 390A
12345